These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36467455)

  • 1. Individualised prediction of drug resistance and seizure recurrence after medication withdrawal in people with juvenile myoclonic epilepsy: A systematic review and individual participant data meta-analysis.
    Stevelink R; Al-Toma D; Jansen FE; Lamberink HJ; Asadi-Pooya AA; Farazdaghi M; Cação G; Jayalakshmi S; Patil A; Özkara Ç; Aydın Ş; Gesche J; Beier CP; Stephen LJ; Brodie MJ; Unnithan G; Radhakrishnan A; Höfler J; Trinka E; Krause R; ; Irelli EC; Di Bonaventura C; Szaflarski JP; Hernández-Vanegas LE; Moya-Alfaro ML; Zhang Y; Zhou D; Pietrafusa N; Specchio N; Japaridze G; Beniczky S; Janmohamed M; Kwan P; Syvertsen M; Selmer KK; Vorderwülbecke BJ; Holtkamp M; Viswanathan LG; Sinha S; Baykan B; Altindag E; von Podewils F; Schulz J; Seneviratne U; Viloria-Alebesque A; Karakis I; D'Souza WJ; Sander JW; Koeleman BPC; Otte WM; Braun KPJ
    EClinicalMedicine; 2022 Nov; 53():101732. PubMed ID: 36467455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis.
    Lamberink HJ; Otte WM; Geerts AT; Pavlovic M; Ramos-Lizana J; Marson AG; Overweg J; Sauma L; Specchio LM; Tennison M; Cardoso TMO; Shinnar S; Schmidt D; Geleijns K; Braun KPJ
    Lancet Neurol; 2017 Jul; 16(7):523-531. PubMed ID: 28483337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors.
    Stevelink R; Koeleman BPC; Sander JW; Jansen FE; Braun KPJ
    Eur J Neurol; 2019 Jun; 26(6):856-864. PubMed ID: 30223294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and meta-analysis of factors related to first line drugs refractoriness in patients with juvenile myoclonic epilepsy (JME).
    Fayad C; Saad K; Kahwagi GJ; Hallit S; Griffin D; Abou-Khalil R; El-Hayek E
    PLoS One; 2024; 19(4):e0300930. PubMed ID: 38593118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizure outcome trajectories in a well-defined cohort of newly diagnosed juvenile myoclonic epilepsy patients.
    Cerulli Irelli E; Morano A; Orlando B; Salamone EM; Fanella M; Fattouch J; Manfredi M; Giallonardo AT; Di Bonaventura C
    Acta Neurol Scand; 2022 Mar; 145(3):314-321. PubMed ID: 34791656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of persistent interictal epileptiform discharges on antiseizure medication withdrawal in patients with epilepsy in five-year remission.
    Liang X; Yu N; Zhang YF; Gu L; Di Q
    Seizure; 2022 Jan; 94():100-106. PubMed ID: 34883461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.
    Strozzi I; Nolan SJ; Sperling MR; Wingerchuk DM; Sirven J
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD001902. PubMed ID: 25922863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001911. PubMed ID: 28240353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Tudur Smith C; Weston J; Marson AG
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD001031. PubMed ID: 27841445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse after treatment withdrawal of antiepileptic drugs for Juvenile Absence Epilepsy and Juvenile Myoclonic Epilepsy.
    Healy L; Moran M; Singhal S; O'Donoghue MF; Alzoubidi R; Whitehouse WP
    Seizure; 2018 Jul; 59():116-122. PubMed ID: 29807291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2015 Aug; (8):CD001911. PubMed ID: 26275105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiseizure Medications Withdrawal Seizures in Patients with Juvenile Myoclonic Epilepsy.
    Hofi E; Medvedovsky M; Nassar M; Khana Levy N; Eyal S; Ekstein D
    Isr Med Assoc J; 2022 Apr; 24(4):253-257. PubMed ID: 35415985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of adults and children following a first unprovoked seizure.
    Neligan A; Adan G; Nevitt SJ; Pullen A; Sander JW; Bonnett L; Marson AG
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD013847. PubMed ID: 36688481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.
    Eaton C; Yong K; Walter V; Mbizvo GK; Rhodes S; Chin RF
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013136. PubMed ID: 35844168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD001904. PubMed ID: 27976799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003615. PubMed ID: 30350354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence rates and risk factors for seizure recurrence following antiseizure medication withdrawal in adolescent patients with genetic generalized epilepsy.
    Komatsubara T; Kobayashi Y; Hiraiwa A; Magara S; Hojo M; Ono T; Okazaki K; Fukuda M; Tohyama J
    Epilepsia Open; 2022 Jun; 7(2):332-343. PubMed ID: 35445562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged epileptic discharges predict seizure recurrence in JME: Insights from prolonged ambulatory EEG.
    Turco F; Bonanni E; Milano C; Pizzanelli C; Steinwurzel C; Morganti R; Fornai F; Maestri M; Siciliano G; Giorgi FS
    Epilepsia; 2021 May; 62(5):1184-1192. PubMed ID: 33735449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2015 Jul; (7):CD001904. PubMed ID: 26204241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.